Blood Pressure Medication Recalled Over Elevated Levels of Carcinogen

 

📰 Blood Pressure Medication Recalled Over Elevated Levels of Carcinogen

A major blood pressure medication has been recalled after tests revealed elevated levels of a potential carcinogen, sparking concern among patients and healthcare providers.

According to the U.S. Food and Drug Administration (FDA), the affected batches contain higher-than-acceptable amounts of nitrosamines — chemical compounds that, with long-term exposure, may increase the risk of cancer. The recall involves several lots of Valsartan, Losartan, and Irbesartan-based products commonly prescribed to treat hypertension and heart failure.

The manufacturer announced the voluntary recall “out of an abundance of caution,” emphasizing that no immediate health risks have been reported so far. However, patients using the affected medications are urged not to stop taking their medicine abruptly, as doing so could pose serious cardiovascular risks. Instead, the FDA advises contacting healthcare providers to discuss safe alternatives or replacement prescriptions.

This is not the first time nitrosamine contamination has led to recalls in blood pressure drugs. Over the past few years, similar incidents have prompted stricter global monitoring of pharmaceutical manufacturing processes.

Consumers can check the FDA’s official recall notice to identify specific batch numbers and affected brands. Pharmacies nationwide are expected to begin removing the impacted products from their shelves immediately.

Would you like me to make this story ready for a news website (SEO format with title, description & tags) or rewrite it for social media/news post style (short & catchy)?